| |
Control |
≤55years |
Secondary glaucoma |
Previous surgery |
Previous topical therapy |
Re-do surgery |
Trainee surgeon |
| Early antifibrotic (% eyes of total) |
18% |
28% |
35%* |
29% |
25% |
23% |
32% |
| Early antifibrotic (no./eye treated) |
1.9 |
2.0 |
1.6 |
2.0 |
1.9 |
1.9 |
1.8 |
| Early antifibrotic rate (mean of total) |
0.34 |
0.56*** |
0.58*** |
0.54*** |
0.49*** |
0.42*** |
0.58*** |
| Odds Ratio |
1.0 |
1.8 |
2.5* |
1.9 |
1.5 |
1.3 |
2.1 |
| Late antifibrotic (Phako surgery censored) (% eyes of total) |
12% |
10% |
13% |
8% |
9% |
11% |
17% |
| Late antifibrotic (Phako surgery censored) (no./eye treated) |
1.4 |
2.5 |
1.0 |
1.7 |
1.3 |
1.3 |
1.8 |
| Late antifibrotic (Phako surgery censored) (mean of total) |
0.20 |
0.25 |
0.16 |
0.13 |
0.12 |
0.13 |
0.44 |
| Odds Ratio |
1.0 |
0.81 |
1.11 |
0.63 |
0.70 |
0.93 |
1.47 |
| *p<0.05, **p<0.01, ***p<0.001 |
